The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
A 2020 vision for vaccines against HIV, tuberculosis and malaria
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
Rerks-Ngarm, S., Pitisuttithum, P., Nitayaphan, S., Kaewkungwal, J., Chiu, J., Paris, R., Premsri, N., Namwat, C., de Souza, M., Adams, E., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0908492 · Cited by 3,034
The Joint United Nations Programme on HIV/AIDS
Nygren-Krug, H. (2018) · Oxford Scholarship Online · doi:10.1093/oso/9780190672676.003.0014 · Cited by 1,950
An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis
Berry, M. P. R., Graham, C. M., McNab, F. W., Xu, Z., Bloch, S. A. A., Oni, T., Wilkinson, K. A., Banchereau, R., Skinner, J., Wilkinson, R. J., et al. (2010) · Nature · doi:10.1038/nature09247 · Cited by 1,898
Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1
Wu, X., Yang, Z.-Y., Li, Y., Hogerkorp, C.-M., Schief, W. R., Seaman, M. S., Zhou, T., Schmidt, S. D., Wu, L., Xu, L., et al. (2010) · Science · doi:10.1126/science.1187659 · Cited by 1,730
Buchbinder, S. P., Mehrotra, D. V., Duerr, A., Fitzgerald, D. W., Mogg, R., Li, D., Gilbert, P. B., Lama, J. R., Marmor, M., del Rio, C., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61591-3 · Cited by 1,713
Comparative Genomics of BCG Vaccines by Whole-Genome DNA Microarray
Behr, M. A., Wilson, M. A., Gill, W. P., Salamon, H., Schoolnik, G. K., Rane, S., & Small, P. M. (1999) · Science · doi:10.1126/science.284.5419.1520 · Cited by 1,542
Global tuberculosis control 2010
Behera, D. (2012) · The Indian Journal of Medical Research · Cited by 1,262
Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans
Querec, T. D., Akondy, R. S., Lee, E. K., Cao, W., Nakaya, H. I., Teuwen, D., Pirani, A., Gernert, K., Deng, J., Marzolf, B., et al. (2009) · Nature Immunology · doi:10.1038/ni.1688 · Cited by 1,121
Self-citationThe rgp120 HIV Vaccine Study Group (2005) · The Journal of Infectious Diseases · doi:10.1086/428404 · Cited by 952
Protective Immunity produced by the Injection of X-irradiated Sporozoites of Plasmodium berghei
NUSSENZWEIG, R. S., VANDERBERG, J., MOST, H., & ORTON, C. (1967) · Nature · doi:10.1038/216160a0 · Cited by 937
Immunity to malaria: more questions than answers
Langhorne, J., Ndungu, F. M., Sponaas, A.-M., & Marsh, K. (2008) · Nature Immunology · doi:10.1038/ni.f.205 · Cited by 878
Stoute, J. A., Slaoui, M., Heppner, D. G., Momin, P., Kester, K. E., Desmons, P., Wellde, B. T., Garçon, N., Krzych, U., Marchand, M., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199701093360202 · Cited by 870
Pitisuttithum, P., Gilbert, P., Gurwith, M., Heyward, W., Martin, M., van Griensven, F., Hu, D., Tappero, J. W., Choopanya, K., & Bangkok Vaccine Evaluation Group (2006) · The Journal of Infectious Diseases · doi:10.1086/508748 · Cited by 847
Alonso, P. L., Sacarlal, J., Aponte, J. J., Leach, A., Macete, E., Milman, J., Mandomando, I., Spiessens, B., Guinovart, C., Espasa, M., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17223-1 · Cited by 752
Hoffman, S. L., Goh, L. M. L., Luke, T. C., Schneider, I., Le, T. P., Doolan, D. L., Sacci, J., de la Vega, P., Dowler, M., Paul, C., et al. (2002) · The Journal of Infectious Diseases · doi:10.1086/339409 · Cited by 688
(1992) · International Journal of Biochemistry · doi:10.1016/0020-711x(92)90281-5 · Cited by 671
Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses
Gaucher, D., Therrien, R., Kettaf, N., Angermann, B. R., Boucher, G., Filali-Mouhim, A., Moser, J. M., Mehta, R. S., Drake, D. R., Castro, E., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20082292 · Cited by 594
A multistage tuberculosis vaccine that confers efficient protection before and after exposure
Aagaard, C., Hoang, T., Dietrich, J., Cardona, P.-J., Izzo, A., Dolganov, G., Schoolnik, G. K., Cassidy, J. P., Billeskov, R., & Andersen, P. (2011) · Nature Medicine · doi:10.1038/nm.2285 · Cited by 527
Chan, M. (2010) · Cited by 514
GlaxoSmithKline Adjuvant Systems in vaccines: concepts, achievements and perspectives
Garçon, N., Chomez, P., & Van Mechelen, M. (2007) · Expert Review of Vaccines · doi:10.1586/14760584.6.5.723 · Cited by 476
Efficacy of RTS,S/AS01E Vaccine against Malaria in Children 5 to 17 Months of Age
Bejon, P., Lusingu, J., Olotu, A., Leach, A., Lievens, M., Vekemans, J., Mshamu, S., Lang, T., Gould, J., Dubois, M.-C., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0807381 · Cited by 417
The Role of Antibodies in HIV Vaccines
Mascola, J. R., & Montefiori, D. C. (2010) · Annual Review of Immunology · doi:10.1146/annurev-immunol-030409-101256 · Cited by 388
Pulendran, B., Li, S., & Nakaya, H. I. (2010) · Immunity · doi:10.1016/j.immuni.2010.10.006 · Cited by 380
Freidlin, B., & Simon, R. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0605 · Cited by 349
Induction of Broadly Neutralizing H1N1 Influenza Antibodies by Vaccination
Wei, C.-J., Boyington, J. C., McTamney, P. M., Kong, W.-P., Pearce, M. B., Xu, L., Andersen, H., Rao, S., Tumpey, T. M., Yang, Z.-Y., et al. (2010) · Science · doi:10.1126/science.1192517 · Cited by 337
Gordon, D. M., McGovern, T. W., Krzych, U., Cohen, J. C., Schneider, I., LaChance, R., Heppner, D. G., Yuan, G., Hollingdale, M., Slaoui, M., et al. (1995) · Journal of Infectious Diseases · doi:10.1093/infdis/171.6.1576 · Cited by 327
Bertholet, S., Ireton, G. C., Ordway, D. J., Windish, H. P., Pine, S. O., Kahn, M., Phan, T., Orme, I. M., Vedvick, T. S., Baldwin, S. L., et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3001094 · Cited by 305
Human gene expression profiles of susceptibility and resistance in tuberculosis
Maertzdorf, J., Repsilber, D., Parida, S. K., Stanley, K., Roberts, T., Black, G., Walzl, G., & Kaufmann, S. H. E. (2011) · Genes & Immunity · doi:10.1038/gene.2010.51 · Cited by 304
Progress and challenges for malaria vaccines
Richie, T. L., & Saul, A. (2002) · Nature · doi:10.1038/415694a · Cited by 303
Advances in tuberculosis vaccine strategies
Skeiky, Y. A. W., & Sadoff, J. C. (2006) · Nature Reviews Microbiology · doi:10.1038/nrmicro1419 · Cited by 299
Kaufmann, S. H., Hussey, G., & Lambert, P.-H. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60393-5 · Cited by 299
Hoffman, S. L., Billingsley, P. F., James, E., Richman, A., Loyevsky, M., Li, T., Chakravarty, S., Gunasekera, A., Chattopadhyay, R., Li, M., et al. (2010) · Human Vaccines · doi:10.4161/hv.6.1.10396 · Cited by 297
Aponte, J. J., Aide, P., Renom, M., Mandomando, I., Bassat, Q., Sacarlal, J., Manaca, M. N., Lafuente, S., Barbosa, A., Leach, A., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61542-6 · Cited by 279
Induction of Immunity to Human Immunodeficiency Virus Type-1 by Vaccination
McElrath, M. J., & Haynes, B. F. (2010) · Immunity · doi:10.1016/j.immuni.2010.09.011 · Cited by 270
Experimental human challenge infections can accelerate clinical malaria vaccine development
Sauerwein, R. W., Roestenberg, M., & Moorthy, V. S. (2011) · Nature Reviews Immunology · doi:10.1038/nri2902 · Cited by 267
Galli, G., Medini, D., Borgogni, E., Zedda, L., Bardelli, M., Malzone, C., Nuti, S., Tavarini, S., Sammicheli, C., Hilbert, A. K., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813390106 · Cited by 261
Self-citationAn HIV Vaccine — Evolving Concepts
Johnston, M. I., & Fauci, A. S. (2007) · New England Journal of Medicine · doi:10.1056/nejmra066267 · Cited by 257
Does malaria suffer from lack of memory?
Struik, S. S., & Riley, E. M. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00181.x · Cited by 238
Molassiotis, A., & Cubbin, D. (2004) · European Journal of Oncology Nursing · doi:10.1016/s1462-3889(03)00054-1 · Cited by 229
Olotu, A., Lusingu, J., Leach, A., Lievens, M., Vekemans, J., Msham, S., Lang, T., Gould, J., Dubois, M.-C., Jongert, E., et al. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70262-0 · Cited by 170
Structure-based antigen design: a strategy for next generation vaccines
Dormitzer, P. R., Ulmer, J. B., & Rappuoli, R. (2008) · Trends in Biotechnology · doi:10.1016/j.tibtech.2008.08.002 · Cited by 169
Self-citationSystems biology of innate immunity
Zak, D. E., & Aderem, A. A. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00721.x · Cited by 169
Self-citationMeningococcal C conjugate vaccine: the experience in England and Wales
Campbell, H., Borrow, R., Salisbury, D., & Miller, E. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.04.067 · Cited by 168
Future Vaccination Strategies against Tuberculosis: Thinking outside the Box
Kaufmann, S. H. E. (2010) · Immunity · doi:10.1016/j.immuni.2010.09.015 · Cited by 166
Rational Design of a Meningococcal Antigen Inducing Broad Protective Immunity
Scarselli, M., Aricò, B., Brunelli, B., Savino, S., Marcello, F. D., Palumbo, E., Veggi, D., Ciucchi, L., Cartocci, E., Bottomley, M. J., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002234 · Cited by 140
Self-citationA Sound Rationale Needed for Phase III HIV-1 Vaccine Trials
Burton, D. R., Desrosiers, R. C., Doms, R. W., Feinberg, M. B., Gallo, R. C., Hahn, B. H., Hoxie, J. A., Hunter, E., Korber, B., LANDAY, A. L., et al. (2004) · Science · doi:10.1126/science.1094620 · Cited by 139
Remarque, E., Faber, B., Kocken, C., & Thomas, A. (2008) · Infection and Immunity · doi:10.1128/iai.00170-08 · Cited by 120
La vaccination preventive contre la tuberculose par le "BCG"
Calmette, A. (1927) · Galiciana (Xunta de Galicia) · Cited by 119
Fitzgerald, D. W., Janes, H., Robertson, M. N., Coombs, R. W., Frank, I., Gilbert, P. B., Loufty, M., Mehrotra, D. V., & Duerr, A. C. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiq114 · Cited by 87
HIV-1 Vaccines and Adaptive Trial Designs
Corey, L., Nabel, G. J., Dieffenbach, C. W., Gilbert, P. B., Haynes, B. F., Johnston, M. I., Kublin, J. G., Lane, H. C., Pantaleo, G., Picker, L. J., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3001863 · Cited by 74
Koup, R. A., Graham, B. S., & Douek, D. C. (2010) · Nature reviews. Immunology · doi:10.1038/nri2890 · Cited by 46
O’Hallahan, J., McNicholas, A., Galloway, Y., O’Leary, E., & Roseveare, C. (2009) · PubMed · Cited by 37
Palermo, R. E., Patterson, L. J., Aicher, L. D., Korth, M. J., Robert-Guroff, M., & Katze, M. G. (2010) · Journal of Virology · doi:10.1128/jvi.01522-10 · Cited by 33
Cited by
The contribution of vaccination to global health: past, present and future
Greenwood, B. (2014) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2013.0433 · Cited by 979
Synthetic Nanoparticles for Vaccines and Immunotherapy
Irvine, D. J., Hanson, M. C., Rakhra, K., & Tokatlian, T. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00109 · Cited by 763
Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles
Singh, A. P., Biswas, A., Shukla, A., & Maiti, P. (2019) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-019-0068-3 · Cited by 645
Carroll, E. C., Jin, L., Mori, A., Muñoz-Wolf, N., Oleszycka, E., Moran, H. B. T., Mansouri, S., McEntee, C. P., Lambe, E., Agger, E. M., et al. (2016) · Immunity · doi:10.1016/j.immuni.2016.02.004 · Cited by 596
Engineering synthetic vaccines using cues from natural immunity
Irvine, D. J., Swartz, M. A., & Szeto, G. L. (2013) · Nature Materials · doi:10.1038/nmat3775 · Cited by 594
Metadata
- Authors
- Rappuoli, R., & Aderem, A.
- Venue
- Nature
- Published
- 2011-05
- Volume
- 473
- Issue
- 7348
- Pages
- 463-469
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1968972970
- Cited by
- 273
- References
- 53
- FWCI
- 12.52
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.